APP and Alzheimer disease: Early work showed that injection of Alzheimer’s disease brain homogenates into young APP23 mice overexpressing amyloid precursor protein (APP) resulted in accelerated disease pathology observed by the presence of Aβ plaques at an earlier age than control animals [4, 9].